Exact Sciences nets FDA breakthrough designation for liver cancer blood test

Exact Sciences announced it received a breakthrough device designation from the FDA for its blood-based test for liver cancer alongside new data demonstrating its sensitivity for early-stage disease.

Sourced through Scoop.it from: www.fiercebiotech.com